Literature DB >> 23558606

New, intensive trials planned on heels of Mississippi HIV 'cure'.

Elie Dolgin.   

Abstract

Mesh:

Substances:

Year:  2013        PMID: 23558606     DOI: 10.1038/nm0413-380

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  1 in total

1.  Planned multiple exposures to autologous virus in HIV type 1-infected pediatric populations increases HIV-specific immunity and reduces HIV viremia.

Authors:  William Borkowsky; Ram Yogev; Petronella Muresan; Elizabeth McFarland; Lisa Frenkel; Terry Fenton; Edmund Capparelli; Jack Moye; Paul Harding; Nina Ellis; Barbara Heckman; Joyce Kraimer
Journal:  AIDS Res Hum Retroviruses       Date:  2008-03       Impact factor: 2.205

  1 in total
  4 in total

Review 1.  Very early combination antiretroviral therapy in infants: prospects for cure.

Authors:  Kaitlin Rainwater-Lovett; Katherine Luzuriaga; Deborah Persaud
Journal:  Curr Opin HIV AIDS       Date:  2015-01       Impact factor: 4.283

Review 2.  Innate antiviral immune signaling, viral evasion and modulation by HIV-1.

Authors:  Arjun Rustagi; Michael Gale
Journal:  J Mol Biol       Date:  2013-12-08       Impact factor: 5.469

Review 3.  Induction of Potent and Long-Lived Antibody and Cellular Immune Responses in the Genitorectal Mucosa Could be the Critical Determinant of HIV Vaccine Efficacy.

Authors:  Nadia Chanzu; Beatrice Ondondo
Journal:  Front Immunol       Date:  2014-05-08       Impact factor: 7.561

Review 4.  Lessons Learned From Failures and Success Stories of HIV Breakthroughs: Are We Getting Closer to an HIV Cure?

Authors:  V Kalidasan; Kumitaa Theva Das
Journal:  Front Microbiol       Date:  2020-01-31       Impact factor: 5.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.